Key facts
- Tetra (London)’s last known valuation is $2.7M (Jan 2026).
- It has raised $610K; the latest was Seed Round ($610K) in Jan 2026.
- Notable investors include Chris Adelsbach, Michael Pennington, Charles Delingpole, Leo Lion.
- Status: Privately Held (backing).
- ·The complete investor list — 4 names
- ·Watchlist + deal alerts for Tetra (London)
- ·The full record, as it builds
Funding rounds
No funding rounds for Tetra (London) are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Tetra (London)
Developer of an operating theatre scheduling platform designed to simplify elective surgery planning and improve session reliability. The company offers intelligent booking logic, procedure time prediction, and integrated clinical data workflows, enabling hospitals and surgical teams to plan theatre lists more accurately and reduce overruns, cancellations, and unused time.
- Sector
- Healthcare
- HQ
- London, United Kingdom
- Founded
- 2025
- Employees
- 5
- Website
- tetratech.uk/
- Ownership
- Privately Held (backing)
Tetra (London) doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Tetra (London) shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Tetra (London) in its N-PORT filings yet. We sweep new filings monthly.